皮肤自发荧光作为晚期糖基化终末产物无创标志物与衰弱相关:鹿特丹研究
结果显示较高的SAF与衰弱前期、衰弱及更高的衰弱指数均相关,提示皮肤AGEs累积可能与衰弱相关,但因果关系尚需纵向研究验证。
要点
- 较高皮肤自发荧光与衰弱前期(OR 1.29)和衰弱(OR 1.87)相关。
- 较高皮肤自发荧光与更高的Rockwood衰弱指数相关(B=0.017)。
- SAF作为无创标志物筛查衰弱的潜力需纵向研究验证。
核心结论
- 较高的皮肤AGEs累积与躯体衰弱和衰弱指数均相关,但因果关系及SAF作为衰弱筛查标志物的潜力尚待纵向研究评估。
研究设计与样本
- 采用多项logistic回归和多变量线性回归,以SAF为暴露、躯体衰弱(有序)和衰弱指数(连续)为结局,校正年龄、性别、糖尿病、肾功能、社会经济状况和吸烟状态。
主要发现
- 参与者平均SAF为2.39±0.49任意单位,年龄中位数74.2(14.0)岁。
- 与非衰弱者相比,SAF与衰弱前期相关(OR 1.29,95%CI 1.07-1.56),与衰弱相关(OR 1.87,95%CI 1.20-2.90)。
- 较高的SAF与更高的衰弱指数相关(系数B=0.017,95%CI 0.011-0.023)。
关键数值与推荐
- Fried躯体衰弱定义包含体重下降、无力、步速慢、疲乏和低体力活动,存在≥3项为衰弱、≤2项为衰弱前期。
- Rockwood衰弱指数包含躯体与心理社会健康领域38项缺陷,评分范围0-1。
- SAF与衰弱前期OR 1.29(95%CI 1.07-1.56)、与衰弱OR 1.87(95%CI 1.20-2.90);SAF与衰弱指数B=0.017(95%CI 0.011-0.023)。
临床怎么用
- 皮肤自发荧光为无创测量,或可作为识别衰弱及衰弱前期风险的辅助标志物,但当前证据仅来自横断面关联,不宜单独用于诊断或筛查决策。
局限性
- 为横断面分析,无法判断皮肤AGEs累积与衰弱之间的因果关系。
- 原文指出需纵向研究评估因果关系及SAF作为衰弱筛查标志物的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accumulation of advanced glycation end-products (AGEs) in tissues has been linked to various age-related disease phenotypes. Therefore, we investigated the potential relationship between skin AGE accumulation and frailty. METHODS: A cross-sectional analysis was performed on 2 521 participants from the Rotterdam Study. Skin AGEs were assessed as skin autofluorescence (SAF) using the AGE reader™. We used 2 approaches to define frailty. Fried's criteria, including weight loss, weakness, slow gait speed, exhaustion, and low physical activity, were used to define physical frailty (presence of ≥3 components) and prefrailty (presence of ≤2 components). Rockwood's concept, including 38 deficits from physical and psychosocial health domains, was used to calculate the frailty index (score 0-1). Multinomial logistic and multivariate linear regression were used with SAF as exposure and physical frailty (ordinal) and frailty index (continuous) as outcome adjusting for age, sex, diabetes, renal function, socioeconomic status, and smoking status. RESULTS: The mean SAF was 2.39 ± 0.49 arbitrary units and the median age was 74.2 (14.0) years. Regarding physical frailty, 96 persons (4%) were frail and 1 221 (48%) were prefrail. Skin autofluorescence was associated with both being prefrail (odds ratio [95% confidence interval] = 1.29 [1.07-1.56]) and frail (1.87 [1.20-2.90]) compared with nonfrail. Regarding the frailty index, the median value was 0.14 (0.10-0.19) and higher SAF was also associated with a higher frailty index (coefficient, B = 0.017 (0.011-0.023]). CONCLUSIONS: Higher skin AGEs are associated with both physical frailty and frailty index. Longitudinal studies are needed to evaluate the causality and the potential of SAF as a biomarker to screen frailty.
引用
- Waqas K, Chen J, Rivadeneira F, et al. Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study. J Gerontol A Biol Sci Med Sci. 2022. PMID: 35099530. doi:10.1093/gerona/glac025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。